Biotie issues convert and new shares

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Biotie issues convert and new shares

microscope_230px
Scientific microscope in the laboratory. | Kurhan - Fotolia

Biotie Therapies raised €83.3m in the first half of the year from the issue of convertible notes and from an initial public offering in the US, the company said on Thursday.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request demo or Login
  • 4,000 annual insights
  • 700+ notes and long-form analyses
  • 4 capital markets databases
  • Daily newsletters across markets and asset classes
  • 2 weekly podcasts
Gift this article